Oncotelic Therapeutics

(OTC) OTLC

Current Price$0.04

Market Cap$16.74M

Since IPO (2019)-66%

5 Year-87%

1 Year-26%

1 Month+0%

Oncotelic Therapeutics Financials at a Glance

Market Cap

$16.74M

Revenue (TTM)

$0.00

Net Income (TTM)

$249.28M

EPS (TTM)

$0.56

P/E Ratio

0.07

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$0.04

Volume

4,339

Open

$0.04

Price

$0.04

Volume

4,339

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.01 - $0.11

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$0.04

Volume

4,339

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.01 - $0.11

OTLC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncotelic Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Vuong Trieu, PhD

Website

www.oncotelic.com

Headquarters

Agoura Hills, CA 91301, US

OTLC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

184%

Return on Capital

-0%

Return on Assets

Earnings Yield

14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.74M

Shares Outstanding

444.20M

Volume

4.34K

Avg. Volume

328.52K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$3.19M

EBITDA

$3.19M

Operating Cash Flow

$1.38T

Capital Expenditure

$0.00

Free Cash Flow

$1.38T

Cash & ST Invst.

$88.86B

Total Debt

$16.27T

Oncotelic Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$16.74M

N/A

Market Cap/Employee

$644.00K

N/A

Employees

N/A

Net Income

$250.35M

+41759.8%

EBITDA

$2.53M

-458.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$16.18T

-124469529.4%

Accounts Receivable

$51.32K

+170.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$16.27T

+124329354.4%

Return on Assets

0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$783.02K

-653.8%

Operating Cash Flow

$783.02K

-653.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$3.55-6.58%

ACHFFArch Biopartners Inc.

ACHFFArch Biopartners Inc.$0.32-0.64%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.45+9.62%

CXXIFC21 Investments Inc.

CXXIFC21 Investments Inc.$0.28-8.90%

PSYBFPsyBio Therapeutics Corp.

PSYBFPsyBio Therapeutics Corp.$0.00+0.00%

CVALFCovalon Technologies Ltd.

CVALFCovalon Technologies Ltd.$1.38-1.03%

INNMFAmplia Therapeutics Limited

INNMFAmplia Therapeutics Limited$0.09-27.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

Questions About OTLC

What is the current price of Oncotelic Therapeutics?

Oncotelic Therapeutics is trading at $0.04 per share.

What is the 52-week range for Oncotelic Therapeutics?

Over the past 52 weeks, Oncotelic Therapeutics has traded between $0.02 and $0.11.

How much debt does Oncotelic Therapeutics have?

As of the most recent reporting period, Oncotelic Therapeutics reported total debt of $14.26M.

How much cash does Oncotelic Therapeutics have on hand?

Oncotelic Therapeutics reported $108,857 in cash and cash equivalents in its most recent financial results.

What is Oncotelic Therapeutics’s dividend yield?

Oncotelic Therapeutics does not currently have a dividend yield.

Oncotelic Therapeutics

Oncotelic Therapeutics Financials at a Glance

OTLC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oncotelic Therapeutics

OTLC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oncotelic Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OTLC

What is the current price of Oncotelic Therapeutics?

What is the 52-week range for Oncotelic Therapeutics?

How much debt does Oncotelic Therapeutics have?

How much cash does Oncotelic Therapeutics have on hand?

What is Oncotelic Therapeutics’s dividend yield?

Premium Investing Services